| SYS | | d000312 |
|---|
| LBL | | 00000cx--j2200000---45-- |
|---|
| 005 | | 20240119201207.7 |
|---|
| 100 | | $a 19990101asloy0103----ba0 |
|---|
| 152 | | $b mesh |
|---|
| 250 | | $a hyperplázia adrenálna vrodená $x BL $x CF $x CI $x CL $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $8 slo |
|---|
| 300 | 1- | $a 80; was ADRENOGENITAL SYNDROME 1963-79 $8 eng |
|---|
| 330 | 1- | $a A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders. $8 eng |
|---|
| 450 | | $a hyperplázia nadobličiek, kongenitálna $5 e $8 slo |
|---|
| 450 | | $a hyperplázia nadobličiek, vrodená $5 e $8 slo |
|---|
| 450 | | $a hyperplázia adrenálna kongenitálna $5 e $8 slo |
|---|
| 550 | | $3 sllk_un_auth*d013741 $Y 3-Oxo-5-alpha-Steroid 4-Dehydrogenase $5 F $a 3-oxo-5-alfa-steroid-4-dehydrogenáza |
|---|
| 550 | | $3 sllk_un_auth*d011629 $Y Puberty, Precocious $5 F $a puberta predčasná |
|---|
| 550 | | $3 sllk_un_auth*d013252 $Y Steroid 11-beta-Hydroxylase $5 F $a steroid-11-beta-hydroxyláza |
|---|
| 550 | | $3 sllk_un_auth*d013254 $Y Steroid 17-alpha-Hydroxylase $5 F $a steroid-17-alfa-hydroxyláza |
|---|
| 550 | | $3 sllk_un_auth*d013255 $Y Steroid 21-Hydroxylase $5 F $a steroid-21-hydroxyláza |
|---|
| 550 | | $3 sllk_un_auth*d014770 $Y Virilism $5 F $a virilizmus |
|---|
| 550 | | $3 sllk_un_auth*d013252 $Y Steroid 11-beta-Hydroxylase $5 B $a steroid-11-beta-hydroxyláza |
|---|
| 550 | | $3 sllk_un_auth*d013254 $Y Steroid 17-alpha-Hydroxylase $5 B $a steroid-17-alfa-hydroxyláza |
|---|
| 675 | | $a 616.45-007.61-056.7 $v UDC-MRF-SK3 $z slo |
|---|
| 686 | | $a C12.050.351.875.253.090.500 |
|---|
| 686 | | $a C12.200.706.316.090.500 |
|---|
| 686 | | $a C12.800.316.090.500 |
|---|
| 686 | | $a C16.131.939.316.129.500 |
|---|
| 686 | | $a C16.320.033 |
|---|
| 686 | | $a C16.320.565.925.249 |
|---|
| 686 | | $a C18.452.648.925.249 |
|---|
| 686 | | $a C19.053.440 |
|---|
| 686 | | $a C19.391.119.090.500 |
|---|
| 750 | | $a Adrenal Hyperplasia, Congenital $8 eng |
|---|
| 801 | -0 | $a US $b DNLM $c 19990101 |
|---|
| 801 | -2 | $a SK $b BA006 $c 20050329 |
|---|
| 801 | -2 | $a SK $b BA006 $c 20091008 |
|---|
| 801 | -2 | $a SK $b BA006 $c 20091013 |
|---|
| 801 | -2 | $a SK $b BA006 $c 20170927 |
|---|
| 980 | | $x M |
|---|
